DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
164 hedge funds and large institutions have $972M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 67 increasing their positions, 48 reducing their positions, and 18 closing their positions.
Holders
164
Holders Change
+7
Holders Change %
+4.46%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
26
Increased
67
Reduced
48
Closed
18
Calls
$636K
Puts
$87K
Net Calls
+$549K
Net Calls Change
+$483K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$74.7M |
2 |
EA
2
Emerald Advisers
Leola,
Pennsylvania
|
$10.8M |
3 |
FLSM
3
Frazier Life Sciences Management
Palo Alto,
California
|
$16.5M |
4 |
AC
4
Armistice Capital
New York
|
$83.9M |
5 |
5
BlackRock
New York
|
$96.4M |